Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group plc (MREO) is a healthcare company (biotechnology) based in the United Kingdom. The share price is $0.27, down 10.00% on the day, which values the company at $43.84M. Price as of 18 Nov 2026, 08:29 UTC, from Yahoo Finance.

Key facts

Share price
$0.27−10.00% today
Market value
$43.84M
200-week average
$1.9786% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Mereo BioPharma Group plc in more detail

MREO trades at -12.7× next year's expected earnings, 54.8× sales. It sits 86% below its 200-week average of $1.97.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Mereo BioPharma Group plc (MREO): questions and answers

What is Mereo BioPharma Group plc's market cap?

Mereo BioPharma Group plc is valued at $43.84M at a share price of $0.27.

Is MREO above its 200-week moving average?

No. MREO is 86.1% below its 200-week average of $1.97. Long-term investors watch that line because strong companies rarely trade below it for long.

Does MREO pay a dividend?

Mereo BioPharma Group plc does not currently pay a regular dividend.

Cite this page

Funkfolio, “Mereo BioPharma Group plc (MREO) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/MREO

Underlying data: Yahoo Finance; company filings with the SEC.